Instruments

Name Stock exchange Average volume Price Type
CHARLES SCHWAB SCHW.PRD

Nyse

37,334 25.09 USD Stock Charles Schwab Stock
CHARLES SCHWAB SCHW.PRJ

Nyse +1 Other

46,270 20.34 USD Stock Charles Schwab Stock
CHARLES SCHWAB SWG0

Deutsche Boerse AG

- 18.3 EUR Stock Charles Schwab
CHARLES SCHWAB SCHW

Nyse +9 Other

7,972,202 76.35 USD Stock Charles Schwab Stock
CHARLES SCHWAB SWG

Deutsche Boerse AG

- 70.4 EUR Stock Charles Schwab
CHARLES SCHWAB 0L3I

London S.E.

59,590 75.61 USD Stock Charles Schwab
CHARLES SCHWAB CORPORATION (THE) 0L3I

CINNOBER BOAT

- 76.35 USD Stock Charles Schwab Corporation (The)
CHARLES SCHWAB SWG

Börse Stuttgart

- 70.4 EUR Stock Charles Schwab
THE CHARLES SCHWAB CORPORATION SCHW

Wiener Boerse

- 69.95 EUR Stock The Charles Schwab Corporation
THE CHARLES SCHWAB CORPORATION SCHW *

Mexican S.E.

103 1,276 MXN Stock The Charles Schwab Corporation
CHARLES SCHWAB SWG

BOERSE MUENCHEN

170 70.83 EUR Stock Charles Schwab
CHARLES SCHWAB SWG

Frankfurt

144 51.45 EUR Stock Charles Schwab
THE CHARLES SCHWAB CORPORATION

Berne S.E.

- 65.01 CHF Stock The Charles Schwab Corporation
CHARLES SCHWAB SCHW34

Sao Paulo

1,961 48.22 BRL Stock Charles Schwab Stock
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL

Nyse +6 Other

507,299 233.5 USD Stock Charles River Laboratories International, Inc. Stock
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. RV6

Deutsche Boerse AG

- 216.4 EUR Stock Charles River Laboratories International, Inc.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. RV6

Börse Stuttgart

- 216.4 EUR Stock Charles River Laboratories International, Inc.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. RV6

BOERSE MUENCHEN

- 217.4 EUR Stock Charles River Laboratories International, Inc.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. RV6

Frankfurt

- 216.6 EUR Stock Charles River Laboratories International, Inc.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL *

Mexican S.E.

1,250 4,049 MXN Stock Charles River Laboratories International, Inc.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. RV6

Berne S.E.

- - CHF Stock Charles River Laboratories International, Inc.
CHARLES & COLVARD, LTD. CTHR

Nasdaq +1 Other

123,436 0.308 USD Stock Charles & Colvard, Ltd. Stock
CHARLES & COLVARD, LTD. CDR

Deutsche Boerse AG

- 0.234 EUR Stock Charles & Colvard, Ltd.
MAC CHARLES (INDIA) LIMITED MCCHRLS-B

Bombay S.E.

239 445.5 INR Stock Mac Charles (India) Limited Stock
CHARLES SCHWAB

Börse Stuttgart

- 93.53 % Obligation Charles Schwab Obligation
CHARLES SCHWAB

Deutsche Boerse AG

- 94.64 % Obligation Charles Schwab Obligation
CHARLES SCHWAB

Deutsche Boerse AG

- 89.29 % Obligation Charles Schwab Obligation

News (61)

Orthofix Medical Inc. Announces Board Changes CI
Engine Capital Management Enters into a Cooperation Agreement with Orthofix Medical CI
Orthofix Announces Agreement with Engine Capital and Appointment of Three New Independent Directors to Further Advance Position as Leading Global Spine and Orthopedics Company BU
Bio Techne : Proxy Statement FY 2023 PU
BIO-TECHNE CORP : Results of Operations and Financial Condition, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K) AQ
GENTHERM INC : Submission of Matters to a Vote of Security Holders (form 8-K) AQ
BIO-TECHNE CORP : Submission of Matters to a Vote of Security Holders (form 8-K) AQ
GENTHERM INC : Submission of Matters to a Vote of Security Holders (form 8-K) AQ
Transcript : Gentherm Incorporated - Shareholder/Analyst Call
Bio Techne : Quarterly Report (SEC Filing - 10-Q) PU
BIO-TECHNE CORP : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K) AQ
Bio Techne : Annual Report FY 2020 PU
GENTHERM INC : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K) AQ
Transcript : Bio-Techne Corporation Presents at 38th Annual J.P Morgan Healthcare Conference, Jan-15-2020 03:00 PM
EY Announces Winners for the Entrepreneur Of The Year® 2019 Heartland Awards BU
BIO TECHNE : FDA Grants Breakthrough Device Designation To Bio-Techne's ExoDx™ Prostate IntelliScore™ (EPI) Test PR
Bio Techne : To Acquire B-MoGen Biotechnologies Inc. PR
EY Announces Finalists for the Entrepreneur Of The Year® 2019 Award in the Heartland BU
Bio-Techne Intends To Seek Acquisitions CI
Transcript : Bio-Techne Corporation - Shareholder/Analyst Call
Gentherm Welcomes Additional Members to its Board of Directors GL
Gentherm Appoints Additional Members to its Board of Directors CI
Bio Techne : To Acquire Exosome Diagnostics, Inc. PR
Bio Techne : To Acquire Quad Technologies PR
Bio Techne : Acquires Atlanta Biologicals Inc. PR
Transcript : Bio-Techne Corporation - Shareholder/Analyst Call
Bio Techne : Acquires Trevigen Inc. PR
Bio-Techne Seeks Acquisitions CI
EY Announces Finalists for the Entrepreneur Of The Year® 2017 Award in the Upper Midwest BU
Bio Techne : Congratulates Astute Medical on Clinical Trial Results PR
BIO TECHNE : COPD Biomarker Qualification Consortium Partners with Bio-Techne to Identify COPD Indicator PR
Bio Techne : Announces Agreement To Acquire Advanced Cell Diagnostics PR
Bio Techne : Acquires Space Import-Export and Strengthens European Leadership Team PU
Bio Techne : Acquires Space Import-Export And Strengthens European Leadership Team PR
Bio Techne : Agrees to Acquire Zephyrus Biosciences, Inc. PR
Bio Techne : Agrees to Acquire Cliniqa Corporation PR
Bio Techne : Announces Appointment of Robert Gavin as Leader of New Protein Platforms Division PU
Techne : Bio-Techne Announces Agreement To Acquire CyVek PR
Techne : Bio-Techne Announces Appointment Of Brenda Furlow As General Counsel PR
Techne : Bio-Techne Announces ProteinSimple Acquisition Completion PU
Techne : Bio-Techne Announces ProteinSimple Acquisition Completion PR
Techne : Technical Updates, License Agreements, and Acquisitions - Analyst Notes on Incyte, BioMarin, Arrowhead, Ligand and Techne PR
Techne : Bio-Techne : Announces Agreement To Acquire Novus Biologicals PR
Techne : Bio-Techne Announces Agreement To Acquire ProteinSimple PR
Techne : Releases Unaudited Third Quarter and Nine Month Fiscal Year 2014 Results PU
12NextSee all

Companies (42)

CHARLES SCHWAB 139 B $
Logo Charles Schwab

The Charles Schwab Corporation specializes in brokerage and banking services. Net sales break down by activity as follows: - brokerage and banking services to individual investors (73.6%); - investment services to institutional investors (26.4%). Beside ...

CHARLES SCHWAB 139 B $
Logo Charles Schwab

The Charles Schwab Corporation specializes in brokerage and banking services. Net sales break down by activity as follows: - brokerage and banking services to individual investors (73.6%); - investment services to institutional investors (26.4%). Beside ...

CHARLES SCHWAB 139 B $
Logo Charles Schwab

The Charles Schwab Corporation specializes in brokerage and banking services. Net sales break down by activity as follows: - brokerage and banking services to individual investors (73.6%); - investment services to institutional investors (26.4%). Beside ...

CHARLES SCHWAB 139 B $
Logo Charles Schwab

The Charles Schwab Corporation specializes in brokerage and banking services. Net sales break down by activity as follows: - brokerage and banking services to individual investors (73.6%); - investment services to institutional investors (26.4%). Beside ...

ENERGY TRANSFER LP 53 514 M $
Logo Energy Transfer LP

Energy Transfer LP owns and operates a diversified portfolios of energy assets in the United States. The Company is engaged in natural gas operations such as natural gas midstream and intrastate transportation and storage, and interstate natural gas trans ...

ENERGY TRANSFER LP 53 514 M $
Logo Energy Transfer LP

Energy Transfer LP owns and operates a diversified portfolios of energy assets in the United States. The Company is engaged in natural gas operations such as natural gas midstream and intrastate transportation and storage, and interstate natural gas trans ...

ENERGY TRANSFER LP 53 514 M $
Logo Energy Transfer LP

Energy Transfer LP owns and operates a diversified portfolios of energy assets in the United States. The Company is engaged in natural gas operations such as natural gas midstream and intrastate transportation and storage, and interstate natural gas trans ...

GAMING AND LEISURE PROPERTIES, INC. 11 729 M $
Logo Gaming and Leisure Properties, Inc.

Gaming and Leisure Properties, Inc. is a self-administered and self-managed Pennsylvania real estate investment trust. The Company's primary business consists of acquiring, financing, and owning real estate property to be leased to gaming operators in tri ...

AÉROPORTS DE PARIS 12 907 M $
Logo Aéroports de Paris

Aéroports de Paris develops and manages airports, including Paris-Charles de Gaulle, Paris-Orly and Paris-Le Bourget. In 2023, the Group handled c. 99.7 million passengers at Paris-CDG and Paris-Orly, and c. 326.7 million passengers abroad. Boasting an ex ...

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 11 989 M $
Logo Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc. specializes in the development of products and services in the field of research and non-clinical drug development for pharmaceutical companies, government agencies and academic institutions. Net sales break ...


1234Next

Insiders

Picture Charles Kummeth
Charles Kummeth

Charles Kummeth currently works at Astronaut Topco LP, as Director.


Picture Charles Kummeth
Charles Kummeth

Charles R. Kummeth holds the position of President, Chief Executive Officer & Director at Bio-Techne Corp. and Chief Executive Officer of ProteinSimple, Chief Executive Officer at Research & Diagnostic Systems, Inc. and President & Director at CyVek, Inc. (which are all subsidiaries of Bio-Techne Corp.). He is also on the board of 5 other companies. In his past career Mr. Kummeth was Vice President-Medical Division at 3M Co. and President-Mass Spectrometry & Chromatography at Thermo Fisher Scientific, Inc. Mr. Kummeth received an undergraduate degree from the University of North Dakota, a graduate degree from the University of St. Thomas (Minnesota) and an MBA from The Curtis L. Carlson School of Management.







No results for this search

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW